Your browser doesn't support javascript.
loading
Successful sequential tyrosine kinase inhibitors to overcome a rare compound of EGFR exon 18-18 and EGFR amplification: A case report.
Wang, Pascal; Fabre, Emmanuelle; Martin, Antoine; Chouahnia, Kader; Benabadji, Ambre; Matton, Lise; Duchemann, Boris.
Afiliación
  • Wang P; Thoracic and Medical Oncology Department, Avicenne Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Bobigny, France.
  • Fabre E; Biochemistry Department, Avicenne Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Bobigny, France.
  • Martin A; INSERM UMR 978, Sorbonne Paris Nord University, Bobigny, France.
  • Chouahnia K; Department of Pathology, Avicenne Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Bobigny, France.
  • Benabadji A; Thoracic and Medical Oncology Department, Avicenne Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Bobigny, France.
  • Matton L; Thoracic and Medical Oncology Department, Avicenne Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Bobigny, France.
  • Duchemann B; Thoracic and Medical Oncology Department, Avicenne Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Bobigny, France.
Front Oncol ; 12: 918855, 2022.
Article en En | MEDLINE | ID: mdl-35957870
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: Francia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: Francia